Influence of iron deficiency definition on the efficacy of intravenous iron in heart failure: a meta-analysis of randomized trials
Einfluss der Definition des Eisenmangels auf die Wirksamkeit von intravenösem Eisen bei Herzinsuffizienz: Metaanalyse randomisierter Studien
Clinical Research in Cardiology · 21.10.2024
DOI: 10.1007/s00392-024-02557-5 ↗Auf einen Blick
Eine Metaanalyse von mehr als 5500 Patient:innen mit Herzinsuffizienz und Eisenmangel zeigte: Der Nutzen von intravenösem Eisen hing von der TSAT ab. Bei TSAT < 20 % war der Effekt günstiger als bei TSAT ≥ 20 %.
Fragestellung
Wie beeinflusst die Definition des Eisenmangels die Wirkung von intravenösem Eisen bei Herzinsuffizienz?
Methode
Random-effects-Metaanalyse von RCTs zu intravenösem Eisen vs. Placebo oder Standardversorgung bei HF und ID; Auswertung von TSAT- und Ferritin-Subgruppen.
Ergebnisse
4 große RCTs mit mehr als 5500 Patient:innen. Bei TSAT < 20 %: RR 0,81 (95 %-KI 0,69–0,94) für CVD oder HFH. Bei TSAT ≥ 20 %: RR 0,98 (95 %-KI 0,79–1,21); Interaktion P = 0,05. Ferritin zeigte keine Modifikation des Effekts.
Schlussfolgerung der Autor:innen
Die Autor:innen schließen, dass der Nutzen von intravenösem Eisen möglicherweise auf Patient:innen mit TSAT < 20 % beschränkt ist, unabhängig vom Ferritin. TSAT < 20 % allein könnte zur Identifikation geeigneter Patient:innen genügen.
Kernaussagen
- TSAT < 20 %: RR 0,81 (95 %-KI 0,69–0,94)
- TSAT ≥ 20 %: RR 0,98 (95 %-KI 0,79–1,21)
- Ferritin beeinflusste den Effekt nicht
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Metaanalyse in der Zeitschrift Clinical Research in Cardiology, online erschienen am 21.10.2024. Verfasst von Pedro Marques und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Centro Hospitalar Universitário de São João, Porto, Portugal. pedro.marques@mail.mcgill.ca. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade do Porto.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Intravenous iron improves symptoms in heart failure (HF) with iron deficiency (ID) but failed to consistently show a benefit in cardiovascular outcomes. The ID definition used may influence the response to intravenous iron. The aim of this meta-analysis is to assess the influence of ID definition on the intravenous iron effect in HF. Methods/Results We performed a random-effects meta-analysis of randomized controlled trials (RCT) on intravenous iron (vs. placebo or standard of care) in patients with HF and ID that provided data on transferrin saturation (TSAT) and ferritin subgroups on the composite outcome of cardiovascular death (CVD) or HF hospitalizations (HFH). The risk ratio (RR) and 95% confidence intervals (95% CI) were extracted on the TSAT (< 20% and ≥ 20%) and ferritin (< 100 ng/mL and ≥ 100 ng/mL) subgroups. Data from four major RCT was collected including a total of more than 5500 patients. In patients with a TSAT < 20%, intravenous iron reduced the composite outcome of CVD or HFH: RR 0.81, 95%CI 0.69–0.94, while in patients with a TSAT ≥ 20% the effect was neutral: RR 0.98, 95%CI 0.79–1.21, interaction, P = 0.05. On the other hand, ferritin levels did not modify the effect of IV iron: ferritin ≥ 100 ng/mL RR 0.84, 95%CI 0.65–1.09, and ferritin < 100 ng/mL RR 0.85, 95%CI 0.74–0.97; interaction, P = 0.96.
Conclusions
Our meta-analysis suggests that the benefit of intravenous iron may be restricted to patients with TSAT < 20% regardless of ferritin levels and supports the single use of TSAT < 20% to identify patients with ID who may benefit from intravenous iron therapy. Graphical abstract In this meta-analysis of > 5500 patients, intravenous iron reduced the composite outcome of CVD or HFH in those with a transferrin saturation (TSAT) < 20%, while for TSAT ≥ 20%, treatment effect was neutral. Ferritin, however, had no impact on intravenous iron response. This analysis suggests that the benefit from intravenous iron may be limited to patients with TSAT < 20%, irrespective of ferritin levels. Utilizing a TSAT < 20% to identify patients with ID who may benefit from intravenous iron therapy should be considered.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Centro Hospitalar Universitário de São João, Porto, Portugal. pedro.marques@mail.mcgill.ca.
- Department of Surgery and Physiology, Cardiovascular Research and Development Center (UnIC@RISE), Faculty of Medicine of the University of Porto, Porto, Portugal. pedro.marques@mail.mcgill.ca.
- Division of Nephrology, McGill University Health Centre, Montreal, QC, Canada. pedro.marques@mail.mcgill.ca.
- Division of Cardiology, DREAM-CV Lab, McGill University Health Centre, Montreal, QC, Canada. pedro.marques@mail.mcgill.ca.
- Department of Internal Medicine, Centro Hospitalar Universitário de São João, Porto, Portugal.
- Department of Surgery and Physiology, Cardiovascular Research and Development Center (UnIC@RISE), Faculty of Medicine of the University of Porto, Porto, Portugal.
Förderung
- Universidade do Porto
Zitieren
APA
Marques, P., Vasques-Nóvoa, F., Matias, P., Vieira, J. T., Mavrakanas, T. A., Sharma, A., Friões, F., & Ferreira, J. P. (2024). Influence of iron deficiency definition on the efficacy of intravenous iron in heart failure: a meta-analysis of randomized trials. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02557-5
Vancouver
Marques P, Vasques-Nóvoa F, Matias P, Vieira JT, Mavrakanas TA, Sharma A, et al. Influence of iron deficiency definition on the efficacy of intravenous iron in heart failure: a meta-analysis of randomized trials. Clinical Research in Cardiology. 2024. doi:10.1007/s00392-024-02557-5
BibTeX
@article{Marques2024,
author = {Marques, Pedro and Vasques-Nóvoa, Francisco and Matias, Paula and Vieira, Joana T and Mavrakanas, Thomas A and Sharma, Abhinav and Friões, Fernando and Ferreira, João Pedro},
title = {Influence of iron deficiency definition on the efficacy of intravenous iron in heart failure: a meta-analysis of randomized trials},
journal = {Clinical Research in Cardiology},
year = {2024},
doi = {10.1007/s00392-024-02557-5}
}
EUVIMED